Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren + amlodipine versus amlodipine alone for ankle foot volume in mild to moderate hypertension
NL-OMON35085Phase 2Recruiting
- Sponsor
- Novartis
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of aliskiren and amlodipine in hypertension (HTN) (2 arms), sponsored by Novartis. Started Mar 2010; status: recruiting.
02
Drugs
aliskirenamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NL-OMON35085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35085.